4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001669866-26-000010
CEO AND PRESIDENT sold 166,000 shares at an average $108.11 ($17,945,451)
- CEO AND PRESIDENT acquired 166,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Garcia Marino · CEO AND PRESIDENT
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-07 | Exercise or conversion : show line 1 in the form 10b5-1 | +40,000 | $8.44 | $337,600 | 105,292 | D |
| 2026-08-07 | Exercise or conversion : show line 2 in the form 10b5-1 | +126,000 | $8.44 | $1,063,440 | 231,292 | D |
| 2026-08-07 | Sale : show line 3 in the form 10b5-1 | −10,384 | $107.49 | $1,116,176 | 220,908 | D |
| 2026-08-07 | Sale : show line 4 in the form 10b5-1 | −23,907 | $108.05 | $2,583,151 | 197,001 | D |
| 2026-08-07 | Sale : show line 5 in the form 10b5-1 | −2,373 | $109.10 | $258,894 | 194,628 | D |
| 2026-08-07 | Sale : show line 6 in the form 10b5-1 | −2,536 | $110.02 | $279,011 | 192,092 | D |
| 2026-08-07 | Sale : show line 7 in the form 10b5-1 | −800 | $110.76 | $88,608 | 191,292 | D |
| 2026-08-07 | Sale : show line 8 in the form 10b5-1 | −104,091 | $107.96 | $11,237,664 | 87,102 | D |
| 2026-08-07 | Sale : show line 9 in the form 10b5-1 | −21,909 | $108.72 | $2,381,946 | 65,292 | D |
| Open-market sales · 166,000 sh · avg $108.11 · $17,945,451 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-07 | Exercise or conversion : show line 10 in the form 10b5-1 Stock Option (Right to Buy) | −40,000 | 286,004 | D |
| 2026-08-07 | Exercise or conversion : show line 11 in the form 10b5-1 Stock Option (Right to Buy) | −126,000 | 160,004 | D |
Loading xslF345X06/ownership.xml…